Literature DB >> 19445758

Anorexia nervosa.

James D Lock1, Kathleen Kara Fitzpatrick.   

Abstract

INTRODUCTION: Anorexia nervosa is characterised by a low body mass index (BMI), fear of gaining weight, denial of current low weight and its impact on health, and amenorrhoea. Estimated prevalence is highest in teenage girls, and up to 0.7% of this age group may be affected. While most people with anorexia nervosa recover completely or partially, about 5% die of the condition, and 20% develop a chronic eating disorder. Young women with anorexia nervosa are at increased risk of bone fractures later in life. METHODS AND OUTCOMES: We conducted a systematic review which aimed to answer the following clinical questions: What are the effects of treatments for anorexia nervosa? What are the effects of interventions to prevent or treat complications of anorexia nervosa? We searched: Medline, Embase, The Cochrane Library, and other important databases up to August 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 40 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: anxiolytic drugs, cyproheptadine, inpatient/outpatient treatment setting, oestrogen treatment, psychotherapy, refeeding, selective serotonin reuptake inhibitors (SSRIs), and tricyclic antidepressants.

Entities:  

Mesh:

Year:  2009        PMID: 19445758      PMCID: PMC2907776     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  69 in total

1.  Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study.

Authors:  Gary R Strokosch; Andrew J Friedman; Shu-Chen Wu; Marc Kamin
Journal:  J Adolesc Health       Date:  2006-12       Impact factor: 5.012

Review 2.  Suicidality in eating disorders: occurrence, correlates, and clinical implications.

Authors:  Debra L Franko; Pamela K Keel
Journal:  Clin Psychol Rev       Date:  2006-07-27

3.  Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.

Authors:  B Timothy Walsh; Allan S Kaplan; Evelyn Attia; Marion Olmsted; Michael Parides; Jacqueline C Carter; Kathleen M Pike; Michael J Devlin; Blake Woodside; Christina A Roberto; Wendi Rockert
Journal:  JAMA       Date:  2006-06-14       Impact factor: 56.272

4.  Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: four-year follow-up study of 41 patients.

Authors:  H G Morgan; G F Russell
Journal:  Psychol Med       Date:  1975-11       Impact factor: 7.723

5.  Predictors of dropout and remission in family therapy for adolescent anorexia nervosa in a randomized clinical trial.

Authors:  James Lock; Jennifer Couturier; Susan Bryson; Stewart Agras
Journal:  Int J Eat Disord       Date:  2006-12       Impact factor: 4.861

6.  Cognitive behavior therapy in the posthospitalization treatment of anorexia nervosa.

Authors:  Kathleen M Pike; B Timothy Walsh; Kelly Vitousek; G Terence Wilson; Joy Bauer
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

7.  Efficacy of citalopram in anorexia nervosa: a pilot study.

Authors:  Secondo Fassino; Paolo Leombruni; Giovanni Daga; Annalisa Brustolin; Giuseppe Migliaretti; Franco Cavallo; Giovanni Rovera
Journal:  Eur Neuropsychopharmacol       Date:  2002-10       Impact factor: 4.600

Review 8.  What is remission in adolescent anorexia nervosa? A review of various conceptualizations and quantitative analysis.

Authors:  Jennifer Couturier; James Lock
Journal:  Int J Eat Disord       Date:  2006-04       Impact factor: 4.861

9.  Cyproheptadine in anorexia nervosa.

Authors:  S C Goldberg; K A Halmi; E D Eckert; R C Casper; J M Davis
Journal:  Br J Psychiatry       Date:  1979-01       Impact factor: 9.319

Review 10.  What can we learn from consumer studies and qualitative research in the treatment of eating disorders?

Authors:  L Bell
Journal:  Eat Weight Disord       Date:  2003-09       Impact factor: 4.652

View more
  7 in total

Review 1.  Anorexia in human and experimental animal models: physiological aspects related to neuropeptides.

Authors:  Mitsuhiro Yoshimura; Yasuhito Uezono; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2015-06-30       Impact factor: 2.781

2.  Translating evidence-based treatment for digital health delivery: a protocol for family-based treatment for anorexia nervosa using telemedicine.

Authors:  A Hambleton; D Le Grange; J Miskovic-Wheatley; S Touyz; M Cunich; S Maguire
Journal:  J Eat Disord       Date:  2020-10-09

3.  Kidney Disease Associated With Anorexia Nervosa: A Case Series With Kidney Biopsies.

Authors:  Hirokazu Marumoto; Takaya Sasaki; Nobuo Tsuboi; Tatsuhiko Ito; Masahiro Ishikawa; Makoto Ogura; Masato Ikeda; Takashi Yokoo
Journal:  Kidney Med       Date:  2020-06-05

4.  Genetic risk for earlier menarche also influences peripubertal body mass index.

Authors:  William Johnson; Audrey C Choh; Joanne E Curran; Stefan A Czerwinski; Claire Bellis; Thomas D Dyer; John Blangero; Bradford Towne; Ellen W Demerath
Journal:  Am J Phys Anthropol       Date:  2013-01       Impact factor: 2.868

5.  The efficacy of family treatments for adolescent anorexia nervosa in specialist versus non-specialist settings: protocol for a systematic review and meta-analysis.

Authors:  Ashlea Hambleton; Phillip Aouad; Jane Miskovic-Wheatley; Daniel Le Grange; Stephen Touyz; Sarah Maguire
Journal:  J Eat Disord       Date:  2022-08-15

6.  Effects of cognitive-behavioral and psychodynamic-interpersonal treatments for eating disorders: a meta-analytic inquiry into the role of patient characteristics and change in eating disorder-specific and general psychopathology in remission.

Authors:  Leif Tore Moberg; Birgitte Solvang; Rannveig Grøm Sæle; Anna Dahl Myrvang
Journal:  J Eat Disord       Date:  2021-06-26

7.  Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders.

Authors:  Phillipa J Hay; Stephen Touyz; Angélica M Claudino; Sanja Lujic; Caroline A Smith; Sloane Madden
Journal:  Cochrane Database Syst Rev       Date:  2019-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.